Skip to content
healthcare.dev

Lacosamide

NDC 46708-173, lacosamide, tablet, film coated, from Alembic Pharmaceuticals Limited.

Product NDC
46708-173
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204974
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE150 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
46708-173-1046708017310100 TABLET, FILM COATED in 1 CARTON (46708-173-10)
46708-173-304670801733030 TABLET, FILM COATED in 1 BOTTLE (46708-173-30)
46708-173-604670801736060 TABLET, FILM COATED in 1 BOTTLE (46708-173-60)
46708-173-91467080173911000 TABLET, FILM COATED in 1 BOTTLE (46708-173-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46b98d5e-fdb6-483a-b022-8b1f0aa832c5

Use it

Look up 46708-173 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.